TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
PRTA

Prothena Corporation plc

Healthcare · Biotechnology

8.70$ -3.4% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

Prothena Corporation plc (PRTA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -164 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow PRTA
Line item 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-9.1 -20 -42 -32 -0.7 -62 -117 -131 -28 -53 -80 93 -109 -134 -150 -164
0.2 0.4 0.5 0.7 0.7 0.8 2.4 3.1 3.2 6.8 1.5 1.1 0.7 0.9 0.9 0.9
1.6 3.0 6.1 3.1 5.6 10 25 27 27 24 22 25 31 41 46 38
– – – 2.6 4.3 5.9 21 22 -1.0 -1.2 -1.7 4.6 20 – – –
1.6 6.6 -7.2 5.7 1.4 11 19 -7.2 94 -4.4 3.5 -10 -19 -21 -68 -4.2
2.6 0.6 1.3 0.6 0.5 1.4 17 3.6 1.8 0.6 0.2 0.6 0.5 2.8 0.3 0.1
-2.6 -0.6 -1.3 -0.5 -0.5 -1.4 -17 -3.5 -1.7 -0.5 -0.2 -0.6 -0.5 -2.8 -0.3 -0.1
– – – 0.0 0.0 0.0 0.0 0.0 – – – – – – – –
– – – 85 118 137 139 168 44 0.2 0.2 94 – – -0.4 -0.1
– – – 14 -0.2 -0.2 -0.2 -2.8 -4.4 – – – – – – –
12 20 168 84 118 141 154 165 40 0.2 0.2 190 241 45 1.6 -0.1
– – 125 52 117 77 20 31 10 -53 -80 282 132 -92 -149 -164
-12 -20 -43 -33 -1.2 -64 -134 -135 -30 -54 -81 92 -109 -137 -150 -164

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?